These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 30951818)

  • 1. Rhamnolipid-involved antibiotics combinations improve the eradication of Helicobacter pylori biofilm in vitro: A comparison with conventional triple therapy.
    Chen X; Li P; Shen Y; Zou Y; Yuan G; Hu H
    Microb Pathog; 2019 Jun; 131():112-119. PubMed ID: 30951818
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preparation and evaluation of lipid polymer nanoparticles for eradicating H. pylori biofilm and impairing antibacterial resistance in vitro.
    Cai J; Huang H; Song W; Hu H; Chen J; Zhang L; Li P; Wu R; Wu C
    Int J Pharm; 2015 Nov; 495(2):728-37. PubMed ID: 26417849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucus penetration enhanced lipid polymer nanoparticles improve the eradication rate of Helicobacter pylori biofilm.
    Li P; Chen X; Shen Y; Li H; Zou Y; Yuan G; Hu P; Hu H
    J Control Release; 2019 Apr; 300():52-63. PubMed ID: 30825476
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of Helicobacter pylori biofilm formation on susceptibility to amoxicillin, metronidazole and clarithromycin.
    Yonezawa H; Osaki T; Hojo F; Kamiya S
    Microb Pathog; 2019 Jul; 132():100-108. PubMed ID: 31034965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Optimum duration of regimens for Helicobacter pylori eradication.
    Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
    Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of biofilm formation by clinical isolates of
    Attaran B; Falsafi T; Ghorbanmehr N
    World J Gastroenterol; 2017 Feb; 23(7):1163-1170. PubMed ID: 28275296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial self-assembled nanodrugs composed of berberine derivatives and rhamnolipids against Helicobacter pylori.
    Shen Y; Zou Y; Chen X; Li P; Rao Y; Yang X; Sun Y; Hu H
    J Control Release; 2020 Dec; 328():575-586. PubMed ID: 32946873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Helicobacter pylori antimicrobial resistance during a 5-year period (2013-2017) in northern Spain and its relationship with the eradication therapies.
    Cosme A; Torrente Iranzo S; Montes Ros M; Fernández-Reyes Silvestre M; Alonso Galán H; Lizasoain J; Bujanda L
    Helicobacter; 2019 Feb; 24(1):e12557. PubMed ID: 30460730
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of Sodium Lauryl Sulfate, Rhamnolipids, and
    Shen Y; Li P; Chen X; Zou Y; Li H; Yuan G; Hu H
    Microb Drug Resist; 2020 Mar; 26(3):290-299. PubMed ID: 31211651
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of Helicobacter pylori biofilm formation on clarithromycin susceptibility and generation of resistance mutations.
    Yonezawa H; Osaki T; Hanawa T; Kurata S; Ochiai K; Kamiya S
    PLoS One; 2013; 8(9):e73301. PubMed ID: 24039906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triple therapy with high-dose proton-pump inhibitor, amoxicillin, and doxycycline is useless for Helicobacter pylori eradication: a proof-of-concept study.
    Almeida N; Romãozinho JM; Donato MM; Luxo C; Cardoso O; Cipriano MA; Marinho C; Sofia C
    Helicobacter; 2014 Apr; 19(2):90-7. PubMed ID: 24506175
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of
    Jin F; Yang H
    Microorganisms; 2021 Jul; 9(8):. PubMed ID: 34442690
    [No Abstract]   [Full Text] [Related]  

  • 13. Vonoprazan-based triple therapy is non-inferior to susceptibility-guided proton pump inhibitor-based triple therapy for Helicobacter pylori eradication.
    Tanabe H; Yoshino K; Ando K; Nomura Y; Ohta K; Satoh K; Ichiishi E; Ishizuka A; Otake T; Kohgo Y; Fujiya M; Okumura T
    Ann Clin Microbiol Antimicrob; 2018 Jun; 17(1):29. PubMed ID: 29950163
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The present status and problems of Helicobacter pylori first-line eradication therapy].
    Tokunaga K; Tanaka A; Sugano H; Takahashi S
    Nihon Rinsho; 2009 Dec; 67(12):2291-6. PubMed ID: 19999114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Helicobacter pylori free-living and biofilm modes of growth: behavior in response to different culture media.
    Bessa LJ; Grande R; Di Iorio D; Di Giulio M; Di Campli E; Cellini L
    APMIS; 2013 Jun; 121(6):549-60. PubMed ID: 23237527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High efficacy of 14-day triple therapy-based, bismuth-containing quadruple therapy for initial Helicobacter pylori eradication.
    Sun Q; Liang X; Zheng Q; Liu W; Xiao S; Gu W; Lu H
    Helicobacter; 2010 Jun; 15(3):233-8. PubMed ID: 20557366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Concomitant therapy achieved the best eradication rate for Helicobacter pylori among various treatment strategies.
    Lee HJ; Kim JI; Lee JS; Jun EJ; Oh JH; Cheung DY; Chung WC; Kim BW; Kim SS
    World J Gastroenterol; 2015 Jan; 21(1):351-9. PubMed ID: 25574111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neither 10- nor 14-Day Sequential Treatment is better than Standard Triple Therapy for Helicobacter Pylori Eradication.
    Warrington E; López-Román O; Tirado Montijo R; Urbina R; Cruz-Correa M; Toro DH
    P R Health Sci J; 2016 Dec; 35(4):203-208. PubMed ID: 27898166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Improved efficacy of proton pump inhibitor - amoxicillin - clarithromycin triple therapy for Helicobacter pylori eradication in low clarithromycin resistance areas or for tailored therapy.
    Prasertpetmanee S; Mahachai V; Vilaichone RK
    Helicobacter; 2013 Aug; 18(4):270-3. PubMed ID: 23356886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel and Effective Therapeutic Regimens for
    Hu Y; Zhu Y; Lu NH
    Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.